Keep away from concomitant utilization of tucatinib with CYP3A substrates, wherever minimum concentration changes may possibly produce major or life-threatening toxicities. If unavoidable, decrease CYP3A substrate dose Based on item labeling. lapatinib will enhance the level or outcome of diazepam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. fludroc... https://stephene714nsw2.shivawiki.com/user